Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Medicine (Baltimore) ; 101(34): e30343, 2022 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-36042644

RESUMO

INTRODUCTION: Thromboangiitis obliterans (TAO) is a rare disease of unknown cause that causes segmental vasculitis in peripheral blood vessels. It is uncertain whether its presence causes serious adverse events in patients receiving external beam radiotherapy. PATIENT CONCERNS: A 73-year-old Japanese man with prostate cancer underwent external beam radiotherapy. DIAGNOSIS: After completion of radiotherapy, fingertip pain occurred, leading to the diagnosis of TAO. INTERVENTIONS: The patient was instructed to stop smoking, but was unable to do so. OUTCOMES: Nine months after the completion of radiotherapy, fecaluria appeared, and a rectourethral fistula was diagnosed by contrast enema. The patient's TAO was poorly controlled, and the patient died from aspiration pneumonia 33 months after completion of the radiotherapy regimen. No tumor recurrence was observed during this process, and there were no risk factors other than TAO that may have formed a rectourethral fistula. LESSONS: This is the first report of rectourethral fistula caused by external beam radiotherapy for prostate cancer in which TAO was suspected to be involved. Although little is known about the relationship between TAO and radiotherapy, it should be noted that radiotherapy itself may increase the risk of normal tissue toxicity in patients with TAO.


Assuntos
Neoplasias da Próstata , Fístula Retal , Tromboangiite Obliterante , Doenças Uretrais , Fístula Urinária , Idoso , Humanos , Masculino , Recidiva Local de Neoplasia/complicações , Neoplasias da Próstata/complicações , Neoplasias da Próstata/radioterapia , Fístula Retal/etiologia , Tromboangiite Obliterante/complicações , Doenças Uretrais/complicações , Fístula Urinária/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...